Postoperative Cognitive Dysfunction is Correlated with Urine Formaldehyde in Elderly Noncardiac Surgical Patients
Overview
Authors
Affiliations
Post-operative cognitive dysfunction (POCD), especially in elderly patients, has been reported in many studies. Although increasing age, duration of anesthesia, postoperative infections, and respiratory complications were regarded as the risk factors for POCD, no extracerebral diagnostic biomarkers have been identified as indicators of POCD. Ninety-five patients, ages 65-80 years, scheduled for major orthopedic or abdominal surgery were enrolled. Twenty-two patients aged between 20 and 40 years undergoing the same procedures served as controls. Subjects received neuropsychological tests one-day prior and one week post procedure. To determine the presence of POCD, the criteria were used as described in most previous studies. Morning urine samples were obtained one day before surgery and on day 1, day 2 and day 7 post operatively. Urine formaldehyde was determined with high-performance liquid chromatography. The urine formaldehyde level of all patients with and without POCD increased on the first 2 days after surgery. But the formaldehyde concentration (on day 7) in patients with POCD was significantly higher than that in patients without POCD (p < 0.01). In the young control group, no patient was diagnosed with POCD. Although the changes in urine formaldehyde of young patients during perioperative period were similar to those in elderly patients without POCD, the formaldehyde concentrations measured at four time points were all significantly lower than those in elderly patients (p < 0.05). Levels of urine formaldehyde were elevated in the perioperative period, with the highest levels at day 7 in patients with POCD. This suggests that the increase on day 7 may provide a new physiologic marker along with neuropsychological assessments to assist in the diagnosis of POCD.
Opposite Roles of Co-enzyme Q10 and Formaldehyde in Neurodegenerative Diseases.
Xu J, Jin X, Ye Z, Wang D, Zhao H, Tong Z Am J Alzheimers Dis Other Demen. 2022; 37:15333175221143274.
PMID: 36455136 PMC: 10624093. DOI: 10.1177/15333175221143274.
Wang Y, Pan F, Xie F, He R, Guo Q Front Aging Neurosci. 2022; 14:820385.
PMID: 35221998 PMC: 8873387. DOI: 10.3389/fnagi.2022.820385.
Current state of research on non-human primate models of Alzheimer's disease.
Li H, Zhang L, Qin C Animal Model Exp Med. 2020; 2(4):227-238.
PMID: 31942555 PMC: 6930996. DOI: 10.1002/ame2.12092.
Jeong H, Chung J, Ko I, Kim S, Jin J, Hwang L Int Neurourol J. 2019; 23(Suppl 2):S93-101.
PMID: 31795608 PMC: 6905212. DOI: 10.5213/inj.1938218.109.
Zhang D, Nie A J Res Med Sci. 2016; 21:73.
PMID: 27904618 PMC: 5121996. DOI: 10.4103/1735-1995.189679.